INBS INTELLIGENT BIO SOLUTIONS INC.

Nasdaq gbs.inc


$ 1.07 $ 0.01 (0.93 %)    

Tuesday, 14-Oct-2025 15:59:50 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 1.08
$ 1.07
$ 1.02 x 907
$ 1.15 x 600
$ 1.02 - $ 1.09
$ 1.01 - $ 2.75
97,000
na
9.7M
$ 2.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-15-2025 06-30-2025 10-K
2 05-13-2025 03-31-2025 10-Q
3 02-13-2025 12-31-2024 10-Q
4 11-07-2024 09-30-2024 10-Q
5 09-18-2024 06-30-2024 10-K
6 05-08-2024 03-31-2024 10-Q
7 02-09-2024 12-31-2023 10-Q
8 11-08-2023 09-30-2023 10-Q
9 08-23-2023 06-30-2023 10-K
10 05-11-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-Q
12 11-14-2022 09-30-2022 10-Q
13 09-22-2022 06-30-2022 10-K
14 05-16-2022 03-31-2022 10-Q
15 02-10-2022 12-31-2021 10-Q
16 11-12-2021 09-30-2021 10-Q
17 09-16-2021 06-30-2021 10-K
18 05-13-2021 03-31-2021 10-Q
19 02-12-2021 12-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 intelligent-bio-solutions-initiates-clinical-studies-for-fingerprint-drug-screening-system-targets-fda-510k-clearance-in-h2-2026-for-codeine-detection

The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening SystemINBS anticipates...

 intelligent-bio-solutions-receives-fda-feedback-preparing-to-resubmit-510k-for-intelligent-fingerprinting-drug-screening-system

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

 intelligent-bio-solutions-posts-60-yoy-growth-in-july-cartridge-sales-surpassing-12500-units

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

 intelligent-bio-solutions-q4-eps-036-sales-843884k-up-from-727824k-yoy

Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.36) per share. The company reported $843.884 thousand...

 intelligent-bio-solutions-secures-major-contract-to-deploy-drug-screening-system-across-londons-public-transport-network

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

 intelligent-bio-solutions-study-confirms-codeine-detection-in-fingerprint-sweat-validating-non-invasive-drug-screening-system

Data shows excretion of codeine in fingerprint sweatINBS' System is viable option for non-invasive diagnostic testingNEW YO...

 intelligent-bio-solutions-sees-accelerated-nordic-adoption-of-fingerprint-drug-testing-through-spjotgard-partnership

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

 intelligent-bio-solutions-integrates-latin-american-spanish-into-intelligent-fingerprinting-drug-screening-system

Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin ...

 intelligent-bio-solutions-q2-eps-050-up-from-207-yoy-sales-60749k-down-from-76406k-yoy

Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.50) per share. This is a 75.85 percent increase over l...

 intelligent-bio-solutions-releases-shareholder-letter

Dear Shareholders,As we begin 2025, I wanted to take the opportunity to recap on the progress we made in 2024 and key upcoming ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION